Artiva Biotherapeutics, Inc. (ARTV) vs Orchestra BioMed Holdings, Inc. (OBIO)
A side-by-side comparison of Artiva Biotherapeutics, Inc. and Orchestra BioMed Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARTV
Artiva Biotherapeutics, Inc.
$7.32HealthcareDelayed quote: Oct 6, 2026, 2:55 PM EDT
OBIO
Orchestra BioMed Holdings, Inc.
$5.91HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
Total return — ARTV vs OBIO
growth of $100 · dividends reinvested · last 2yARTV -40.6% (-22.9%/yr)OBIO -24.9% (-13.3%/yr)OBIO compounded faster over this window
ARTV OBIO
ARTV vs OBIO: by the numbers
- •ARTV is the larger company ($358M vs $354M market cap).
- •Both run net losses; ARTV's is the smaller (0.00% vs -184.60% net margin).
Metrics side by side
Valuation
| Metric | ARTV | OBIO |
|---|---|---|
| P/S ratio | N/A | 11.06 |
| P/B ratio | 1.03 | 18.30 |
Profitability
| Metric | ARTV | OBIO |
|---|---|---|
| Gross margin | 0.00% | 99.32% |
| Operating margin | 0.00% | -154.73% |
| Net margin | 0.00% | -184.60% |
| ROE | -26.14% | -200.64% |
| ROIC | -27.16% | -56.73% |
Growth (annualized)
| Metric | ARTV | OBIO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 148.45% |
| Total return CAGR (5Y) | N/A | -9.35% |
Go deeper
Dig into the metrics
Artiva Biotherapeutics ROEOrchestra BioMed ROEArtiva Biotherapeutics operating marginOrchestra BioMed operating marginArtiva Biotherapeutics revenue growthOrchestra BioMed revenue growthArtiva Biotherapeutics free cash flowOrchestra BioMed free cash flow
Artiva Biotherapeutics & Orchestra BioMed appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.